Cargando…
Potential Use of Janus Kinase Inhibitors in the Treatment of Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease with unclear pathogenesis. One characteristic of SLE is pro-inflammatory and anti-inflammatory cytokine imbalance. Janus kinase (JAK) is an intracellular non-receptor tyrosine kinase essential for many cytokine signaling pathways. D...
Autores principales: | Huo, Rongxiu, Huang, Xinxiang, Yang, Yang, Lin, Jinying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084827/ https://www.ncbi.nlm.nih.gov/pubmed/37051062 http://dx.doi.org/10.2147/JIR.S397639 |
Ejemplares similares
-
Systemic lupus erythematosus with diffuse alveolar hemorrhage
por: Huo, Rongxiu, et al.
Publicado: (2023) -
Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition
por: Nikolopoulos, Dionysis, et al.
Publicado: (2023) -
Potential of resveratrol in the treatment of interstitial lung disease
por: Huo, Rongxiu, et al.
Publicado: (2023) -
Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease
por: Huo, Rongxiu, et al.
Publicado: (2022) -
Mortality associated with Sjögren’s syndrome in the United States in the 1999–2020 period: A multiple cause-of-death study
por: Huo, Rongxiu, et al.
Publicado: (2023)